The Treatment of Liver Metastases in Patients with Neuroendocrine Tumors in 2012

Neuroendocrine tumors (NETs) comprise a heterogeneous group of tumors that form a distinct entity. Approximately 75–80% of patients present with liver metastases at the time of their diagnosis, and 20%–25% will develop these lesions in the course of their disease. The presence of secondary deposits...

Descripción completa

Detalles Bibliográficos
Autores principales: Macedo, Daniela, Amaral, Teresa, Fernandes, Isabel, Sousa, Ana Rita, Costa, Ana Lúcia, Távora, Isabel, Quintela, António, Cortes, Paulo, Costa, Luís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890909/
https://www.ncbi.nlm.nih.gov/pubmed/27335831
http://dx.doi.org/10.1155/2013/702167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890909/
https://www.ncbi.nlm.nih.gov/pubmed/27335831
http://dx.doi.org/10.1155/2013/702167

Ejemplares similares